European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

  1. Coghill, D.
  2. Banaschewski, T.
  3. Lecendreux, M.
  4. Soutullo, C.
  5. Johnson, M.
  6. Zuddas, A.
  7. Anderson, C.
  8. Civil, R.
  9. Higgins, N.
  10. Lyne, A.
  11. Squires, L.
Journal:
European Neuropsychopharmacology

ISSN: 0924-977X 1873-7862

Year of publication: 2013

Volume: 23

Issue: 10

Pages: 1208-1218

Type: Article

DOI: 10.1016/J.EURONEURO.2012.11.012 GOOGLE SCHOLAR lock_openOpen access editor